# Beijing Zhizhen Biotechnology Co.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/beijing-zhizhen-biotechnology-co

- Industry: Medical Devices & Equipment
- Headquarters: Beijing, China
- Website: www.gaugene.com
- Total disclosed funding: $48M
- Latest round: Series B (Jul 15, 2022)
- Investors on record: 12

## About

provides hematology testing equipment and reagent services for in vitro diagnostic users. The company team members have been engaged in the research and development of related products and provided solutions for clinical hematology diagnosis. The company raised angel funding in 2018 and raised pre-A and series A funding in 2020. Many members of the team comes from many medical companies such as Shenzhen Mindray Bio-Medical Electronics Co., Ltd. and Beijing Leadman Biochemistry Co., Ltd.

The company focuses on the research and development of flow fluorescence technology, providing hematology diagnostic products and solutions for clients. Its products including blood immune integrated machine and cytokine multi-factor detection reagent already used in many hospitals.

The company plans to expand and update its product lines of flow fluorescence and blood cell immunity in the future. Following the funding in 2021, the company plans to use the investment to accelerate the company's product market development and the development of new technologies and new products.

## Funding rounds

- Series B, Jul 15, 2022, $15M — Qiming Venture Partners, Fortune Capital, Guangzhou LBP Medicine Science & Technology Co., Ltd., Guangdong Hybribio Biotech, Tao Capital, Huihe Capital
- Series B, Jan 2, 2022, $16M — Fuhe Capital, Huaxia Hengtian Asset Management
- Series A, Jun 18, 2021 — Qiming Venture Partners
- Series A, Aug 20, 2020, $14M — Sharewin Investment, HighLight Capital, E-Town International Industrial Investment
- Angel, Aug 1, 2018, $3M — HighLight Capital, MED-FINE Capital

## Investors

- HighLight Capital (https://capitalatlas.ai/funds/highlight-capital) — Angel, Series A
- MED-FINE Capital (https://capitalatlas.ai/funds/med-fine-capital) — Angel
- Sharewin Investment (https://capitalatlas.ai/funds/sharewin-investment) — Series A
- E-Town International Industrial Investment (https://capitalatlas.ai/funds/e-town-international-industrial-investment) — Series A
- Qiming Venture Partners (https://capitalatlas.ai/funds/qiming-venture-partners) — Series A, Series B
- Fuhe Capital — Series B
- Huaxia Hengtian Asset Management (https://capitalatlas.ai/funds/huaxia-hengtian-asset-management) — Series B
- Fortune Capital — Series B
- Guangzhou LBP Medicine Science & Technology Co., Ltd. — Series B
- Guangdong Hybribio Biotech — Series B
- Tao Capital (https://capitalatlas.ai/funds/tao-capital) — Series B
- Huihe Capital — Series B